Literature DB >> 27371838

[Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].

Dan Hu1, Zheng Jiang2.   

Abstract

Objective To explore the effect of phospholipase C δ1 (PLCD1) transfection on the biological behaviors of pancreatic cancer cells. Methods HPDE6C7 normal human pancreatic ductal epithelial cells and CAPAN-1, PANC-1, ASPC-1 and BXPC-3 pancreatic cancer cells were cultured. Reverse transcription PCR was used to screen the pancreatic cancer cells with low expression level of PLCD1. Recombinant plasmid pcDNA3.1-PLCD1 transfected pancreatic cancer cells CAPAN-1 and BXPC-3 with low expression level of PLCD1, and meanwhile the corresponding vector pcDNA3.1 transfection group was set up. The expression level of PLCD1 mRNA was detected by reverse transcription PCR, and the protein level was examined by Western blotting in pancreatic cancer cells CAPAN-1 and BXPC-3 after transfection. After the expression of PLCD1 was upregulalted in CAPAN-1 and BXPC-3 pancreatic cancer cells, the cell proliferation was analyzed by CCK-8 assay; flow cytometry was used to test the cell cycle and apoptosis; Transwell(TM) assay was performed to evaluate the invasion and migration ability of the cells. Results The study obtained CAPAN-1 and BXPC-3 cells with lower expression of PLCD1. The expression levels of PLCD1 mRNA and protein obviously increased in CAPAN-1 and BXPC-3 cells after transfected with plasmid pcDNA3.1-PLCD1, and the abilities of cell proliferation, invasion and migration were restrained. The cell cycle was arrested in G0/G1 phase, and cell apoptosis was remarkably promoted. Conclusion PLCD1 transfection can induce the apoptosis of CAPAN-1 and BXPC-3 cells, arrest the cell cycle in G0 /G1 phase. Meanwhile, it inhibits the abilities of cell proliferation, invasion and migration of CAPAN-1 and BXPC-3 cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27371838

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  6 in total

1.  Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Yao Jian; Qing Qiao; Juanjuan Tang; Xiaobing Qin
Journal:  Oncol Lett       Date:  2022-06-10       Impact factor: 3.111

2.  Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.

Authors:  Ying Yue; Mengjia Song; Yamin Qiao; Pupu Li; Yiqiang Yuan; Jingyao Lian; Suying Wang; Yi Zhang
Journal:  Oncotarget       Date:  2017-10-30

3.  Abnormalities of hair structure and skin histology derived from CRISPR/Cas9-based knockout of phospholipase C-delta 1 in mice.

Authors:  Yu-Min Liu; Wei Liu; Jun-Shuang Jia; Bang-Zhu Chen; Heng-Wei Chen; Yu Liu; Ya-Nan Bie; Peng Gu; Yan Sun; Dong Xiao; Wei-Wang Gu
Journal:  J Transl Med       Date:  2018-05-25       Impact factor: 5.531

4.  Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms.

Authors:  Xin Zhou; Xiwen Liao; Xiangkun Wang; Ketuan Huang; Chengkun Yang; Tingdong Yu; Chuangye Han; Guangzhi Zhu; Hao Su; Quanfa Han; Zijun Chen; Jianlv Huang; Yizhen Gong; Guotian Ruan; Xinping Ye; Tao Peng
Journal:  Cancer Med       Date:  2019-12-06       Impact factor: 4.452

5.  Effects of Dietary Threonine Levels on Intestinal Immunity and Antioxidant Capacity Based on Cecal Metabolites and Transcription Sequencing of Broiler.

Authors:  Shuyun Ji; Xi Qi; Shuxue Ma; Xing Liu; Yuna Min
Journal:  Animals (Basel)       Date:  2019-09-28       Impact factor: 2.752

6.  Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.

Authors:  JinHui Liu; YiCong Wan; Siyue Li; HuaiDe Qiu; Yi Jiang; Xiaoling Ma; ShuLin Zhou; WenJun Cheng
Journal:  Cancer Med       Date:  2020-03-14       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.